Lipoprotein lipase (LP lipase, triacylglyceroprotein acyihydrolase EC 3.1.1.34) activity was found in four dissimilar brain regions (hypothalamus, cortex, cerebellum, and midbrain) of adult male rats. Progressive accumulation of LP lipase activity in cultured fetal rat hypothalamic cells was also observed, indicating de novo synthesis of the lipase. The brain LP lipase activity was serum-dependent and was inhibited by 1 (2) or assimilated from the plasma compartment either from albumin-bound nonesterified fatty acids or from fatty acids liberated by triacylglycerol-rich lipoprotein (chylomicron or very low density lipoprotein) triacylglycerol hydrolysis. This hydrolysis would be dependent on lipoprotein lipase (LP lipase, triacylglycero-protein acylhydrolase, EC 3.1.1.34), an enzyme produced in a number of extracranial tissues, including muscle, adipose tissue, and lactating breast (3). Smaller amounts of LP lipase have been detected in rat brain (4). However, in studies of rabbit brain microvessels, the enzyme was examined only on the endothelial surface (5), the site of triacylglycerol-rich lipoprotein triacylglycerol hydrolysis in other tissues (3).
The brain is rich in lipids (>50% of dry weight) and has a high content of fatty acids, most of which are incorporated into phospholipids (40% of brain lipid) or glycolipids (35% of brain lipid) (1) . Fatty acids contained in brain phospholipids, glycolipids, or other neutral lipids could be synthesized in the brain (2) or assimilated from the plasma compartment either from albumin-bound nonesterified fatty acids or from fatty acids liberated by triacylglycerol-rich lipoprotein (chylomicron or very low density lipoprotein) triacylglycerol hydrolysis. This hydrolysis would be dependent on lipoprotein lipase (LP lipase, triacylglycero-protein acylhydrolase, EC 3.1.1.34), an enzyme produced in a number of extracranial tissues, including muscle, adipose tissue, and lactating breast (3) . Smaller amounts of LP lipase have been detected in rat brain (4) . However, in studies of rabbit brain microvessels, the enzyme was examined only on the endothelial surface (5), the site of triacylglycerol-rich lipoprotein triacylglycerol hydrolysis in other tissues (3) .
Brain LP lipase could not only be an important source of fatty acids for brain cell lipid but could also serve as a metabolic regulator. For instance, increases in LP lipase-mediated fatty acid delivery to the hypothalamus could be a mechanism by which alterations in food intake are regulated. We provide evidence that LP lipase is present in several brain regions, is synthesized by and functional in brain cells in vitro, and is subject to regulation in vivo by fasting. It is the latter observation that strongly suggests a regulatory role of the enzyme in the brain. 
MATERIALS AND METHODS
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Whole Brain Fragments. The presence of LP lipase in adult brain was determined in adult Sprague-Dawley rats (219 + 16 g, range 147-310 g) who either had unlimited access to standard rat lab chow and water (fed) or were deprived of rat chow but not water for 72 hr (fasted). Rats were anesthetized and then perfused with ice-cold phosphate-buffered saline via the left cardiac ventricle to remove blood from the brain. Brains were rapidly removed and dissected at 40C into the following major regions: frontal cortex, hypothalamus, cerebellum, and midbrain. Regional dissections using standard surface landmarks were performed using the method of McEwen and Pfaff (10) . Samples (40-45 mg) from each region were kept at 40C, weighed, minced, and immediately incubated in Krebs-Ringer solution containing heparin.
The Wilcoxin matched-pairs signed-ranks test and the Mann-Whitney U test were used for statistical analyses.
RESULTS
Hypothalamic Cell Cultures. LP lipase in medium that had been added to cultures 24 hr before measurement rose from undetectable amounts on day 1 to 0.40 + 0.08 nmol minper 106 cells (+SEM, n = 4) by the third week in vitro (Fig.  1) . No cultures older than this were examined.
LP lipase released from cell monolayers into Krebs-Ringer solution containing heparin (45 min incubation) likewise rose from undetectable levels on day 0 to 0.39 + 0.07 nmol min-' per 106 cells (n = 6) by the third week in vitro. The dependence of LP lipase activity on protein synthesis was shown in 2-week-old cultures by 73 + 7% (n = 2) and 74 ± 1% (n = 2) decreases in heparin-released LP lipase 2 and 4 hr, respectively, after the addition of cycloheximide (1 pug/ml) to the cultures. To investigate the dependency on serum activators, we omitted serum from the assay: heparinreleased LP lipase activity decreased from 0.21 ± 0.05 to 0.05 ± 0.02 (n = 11). As shown for LP lipase in other systems (3), no LP lipase activity was detected when 1 M NaCl or protamine sulfate (3 mg/ml) was added to the assay.
Triacylglycerol Fatty Acid Incorporation into Cell Lipids.
Exposure of cultured brain cells to emulsified [14C]triolein
substrate resulted in time-dependent uptake and incorporation of label into cellular lipids. Incorporation into total cellular lipids was 0.16 ± 0.06% (n = 6) at 0.5 hr, 0.36 ± 0.07% (n = 7) at 2 hr, and 0.99 ± 0.32% (n = 4) at 24 hr.
To determine the fate of incorporated label, both the polar and the nonpolar lipid fractions were subjected to thin-layer chromatography and autoradiography. A solvent system of petroleum ether, diethyl ether, and acetic acid (160:40:2, vol/vol) was optimal for separation of nonpolar lipids. At 0.5 hr, incorporation into nonpolar lipids had occurred (>200 cpm above background) but was below the level of detection by autoradiography. At 24 hr, incorporation into cellular triacylglycerol was seen (Fig. 2) . The two radioactive bands in the region of fatty acid migration appeared to be oleic acid and a more polar fatty acid, resulting from either desaturation or fatty acid chain-length shortening. Both of these processes take place in brain (2) . Polar lipids were optimally separated by thin-layer chromatography in chloroform/methanol/water (140:50:8, vol/ vol) (Fig. 3) . The radioactivity in the triacylglycerol area and in a fatty acid area (Fig. 3, 24 -hr lane) is due to incomplete removal of nonpolar lipids by the silicic acid precipitation step prior to chromatography. At 0.5 hr, radioactivity was present in silicic acid-precipitated lipids but was not detectable by autoradiography. By 24 hr, incorporation into phosphatidylcholine (PC), seen as a faint band, and sphingomyelin (SM) was observed. (12) have shown that the uptake of [14C]palmitate into brain lipid is at least partially dependent on the delivery of the fatty acid in the form of triacylglycerol-rich lipoprotein.
LP lipase activity was also regulated in vivo by fasting. Although LP lipase activity decreased in all brain regions, the largest decrease occurred in hypothalamic LP lipase. LP lipase-dependent fatty acid uptake into brain cells in the hypothalamus is particularly noteworthy because food intake and body weight are to a large extent regulated in this brain region (13, 14) . Lesions in the ventromedial nucleus of the hypothalamus in rats result in increased food intake and weight gain (15) ; similar lesions in the lateral hypothalamus variably cause decreases in food intake and weight loss (15, 16) . After such lesions occur, adaptation and regulation of food intake and body weight at a new level then occur. Based on these observations, an integrated hypothesis might relate LP lipase-dependent fatty acid uptake in the ventromedial nucleus to suppression of food intake by as yet unidentified intra-and intercellular events. Alternatively, decreases in LP lipase-mediated fatty acid uptake during fasting could stimulate increases in food intake. Because the entire hypothalamus was used for our studies, such hypothesis would suggest a predominant regulatory role of the ventromedial nucleus over the lateral hypothalamus in such a process.
The observation that heparin-released LP lipase increases with time in isolated hypothalamic cells in vitro and that the activity of the enzyme is inhibited by cycloheximide verify that cells in this brain region have the capacity to synthesize the lipase activity de novo. The loss of activity in the absence of serum, as well as the inhibition by NaCl and protamine sulfate, confirm that this activity is authentic LP lipase (3) .
Although human neuroblastoma cell line NBP2 (17) contained only small amounts of LP lipase activity (0.02 ± 0.02 nmol min-1 per 106 cells, n = 2), we have no direct evidence that glial cells are the source of the enzyme. An alternative source of LP lipase could be the microvascular endothelium. However, evidence for endothelial production of LP lipase in other tissues-e.g., aorta (18) and adipose tissue (19)-is lacking.
In conclusion, we have identified LP lipase activity in several brain regions, shown that isolated brain cells synthesize the enzyme, provided evidence for triacylglycerol fatty acid incorporation into brain cell lipids, and shown in vivo regulation of LP lipase in response to the metabolic challenge of fasting. Thus, LP lipase may not only be important in the regulation of brain lipid metabolism but could serve as a regulator or mediator of certain hypothalamic functions, including body-weight regulation and appetite control.
